Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra and currently employs 627 full-time employees. The company went IPO on 2015-01-20. The firm is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The firm manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. Its products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances and health care.

Camlin Fine Dividends

532834.BO dividend metrics

Dividend per share

532834.BO dividend history